logo

For the Inventor, By the Inventor

Osaka, Japan

Masahiro Kajino

This inventor holds 16 USPTO granted patents and 5 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Kajino. Retrieved from https://idiyas.com/inventor/masahiro-kajino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 62.5

 

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 91(Granted Patents)


Company Filing History:

goldMedal16 out of 1,226 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2008-2019

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 10308605 - Proton pump inhibitors (2019-06-04),
2. 8933105 - Pyrrole compounds (2015-01-13),
3. 8436187 - 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors (2013-05-07),
4. 8415368 - Acid secretion inhibitor (2013-04-09),
5. 8338462 - 1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors (2012-12-25),
6. 8338461 - 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors (2012-12-25),
7. 8299261 - 1-heterocyclylsulfonyl, 3-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors (2012-10-30),
8. 8048909 - Proton pump inhibitors (2011-11-01),
9. 7977488 - 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors (2011-07-12),
10. 7973163 - Fused quinoline derivative and use thereof (2011-07-05),
11. 7943770 - Fused quinoline derivative and use thereof (2011-05-17),
12. 7767665 - 1,3-benzothiazinone derivatives and use thereof (2010-08-03),
13. 7659267 - 1,3-Benzothiazinone derivatives, process for producing the same use thereof (2010-02-09),
14. 7592453 - Fused quinoline derivative and use thereof (2009-09-22),
15. 7498337 - Acid secretion inhibitor (2009-03-03),

Title: Masahiro Kajino - Innovator in Proton Pump Inhibitors

Introduction

Masahiro Kajino is a notable inventor based in Osaka, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of 16 patents, he has made strides in the development of innovative medical treatments, particularly in the area of proton pump inhibitors and pyrrole compounds.

Latest Patents

Kajino's latest inventions include advancements in proton pump inhibitors, which focus on compounds designed to enhance proton pump action and exhibit antiulcer activities. His formulation involves complex arrangements of hydrocarbons and heterocyclic groups, providing a robust pharmaceutical benefit. Another of his latest patents emphasizes the creation of pyrrole compounds, which are characterized by their superior acid secretion inhibitory effects. These compounds have been meticulously designed to deliver antiulcer activity, showing promising potential in therapeutic applications.

Career Highlights

Masahiro Kajino is affiliated with Takeda Pharmaceutical Company Limited, a leader in research and development in the pharmaceutical industry. His work has consistently demonstrated innovation and a commitment to improving health outcomes through scientific discovery. His 16 patents highlight his expertise and prolific nature as an inventor.

Collaborations

Throughout his career, Kajino has collaborated with several talented individuals at Takeda Pharmaceutical Company Limited. Notable coworkers include Atsushi Hasuoka and Haruyuki Nishida, with whom he has driven forward groundbreaking research and development in the field of pharmaceuticals. Their collective efforts have contributed to the successful launch of new drugs and treatment options for patients.

Conclusion

Masahiro Kajino stands out as an influential inventor whose work in proton pump inhibitors and pyrrole compounds is paving the way for advanced medical therapies. His contributions reflect not only his exceptional skill as an inventor but also a dedication to improving patient care through innovative solutions in the pharmaceutical domain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…